➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
McKesson
Medtronic
Merck

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Aminophylline In Sodium Chloride 0.45%

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00130598 ↗ PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION Completed Swiss National Science Foundation Phase 2/Phase 3 2005-06-01 Contrast nephropathy (CN) remains a common complication of radiographic procedures and an important cause of hospital-acquired acute renal failure. Only hydration with saline is uniformly accepted and used in clinical practice as a cornerstone for the prevention of CN. But the optimal preventive strategy for CN is not known. Sodium bicarbonate might be even more effective than hydration with sodium chloride for prophylaxis of CN. Therefore the aim of the study is to evaluate the efficacy of two regimens of sodium bicarbonate compared with a prolonged infusion of sodium chloride in the prevention of CN. Primary endpoint: Decrease in glomerular filtration rate (GFR) within 48 hours.
NCT00130598 ↗ PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION Completed University Hospital, Basel, Switzerland Phase 2/Phase 3 2005-06-01 Contrast nephropathy (CN) remains a common complication of radiographic procedures and an important cause of hospital-acquired acute renal failure. Only hydration with saline is uniformly accepted and used in clinical practice as a cornerstone for the prevention of CN. But the optimal preventive strategy for CN is not known. Sodium bicarbonate might be even more effective than hydration with sodium chloride for prophylaxis of CN. Therefore the aim of the study is to evaluate the efficacy of two regimens of sodium bicarbonate compared with a prolonged infusion of sodium chloride in the prevention of CN. Primary endpoint: Decrease in glomerular filtration rate (GFR) within 48 hours.
NCT00312273 ↗ Aminophylline in Bradyasystolic Cardiac Arrest Completed Heart and Stroke Foundation of Canada Phase 2 2001-01-01 The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest.
NCT00312273 ↗ Aminophylline in Bradyasystolic Cardiac Arrest Completed Vancouver Coastal Health Research Institute Phase 2 2001-01-01 The purpose of this study is to evaluate the effect of aminophylline in patients with out-of-hospital bradyasystolic cardiac arrest.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Aminophylline In Sodium Chloride 0.45%

Condition Name

Condition Name for Aminophylline In Sodium Chloride 0.45%
Intervention Trials
Acute Kidney Injury 3
Asthma 2
Postoperative Complications 2
Physiological Function in Low Oxygen Environment 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Aminophylline In Sodium Chloride 0.45%
Intervention Trials
Acute Kidney Injury 4
Altitude Sickness 3
Wounds and Injuries 3
Asthma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Aminophylline In Sodium Chloride 0.45%

Trials by Country

Trials by Country for Aminophylline In Sodium Chloride 0.45%
Location Trials
United States 12
China 7
Italy 2
United Kingdom 2
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Aminophylline In Sodium Chloride 0.45%
Location Trials
Illinois 3
Colorado 2
North Carolina 2
California 2
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Aminophylline In Sodium Chloride 0.45%

Clinical Trial Phase

Clinical Trial Phase for Aminophylline In Sodium Chloride 0.45%
Clinical Trial Phase Trials
Phase 4 9
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Aminophylline In Sodium Chloride 0.45%
Clinical Trial Phase Trials
Completed 16
Recruiting 5
Active, not recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Aminophylline In Sodium Chloride 0.45%

Sponsor Name

Sponsor Name for Aminophylline In Sodium Chloride 0.45%
Sponsor Trials
Rush University Medical Center 3
Peking University First Hospital 2
Stanford University 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Aminophylline In Sodium Chloride 0.45%
Sponsor Trials
Other 33
U.S. Fed 3
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Colorcon
Merck
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.